Literature DB >> 24740287

Mutant TDP-43 deregulates AMPK activation by PP2A in ALS models.

Nirma D Perera, Rebecca K Sheean, John W Scott, Bruce E Kemp, Malcolm K Horne, Bradley J Turner.   

Abstract

Bioenergetic abnormalities and metabolic dysfunction occur in amyotrophic lateral sclerosis (ALS) patients and genetic mouse models. However, whether metabolic dysfunction occurs early in ALS pathophysiology linked to different ALS genes remains unclear. Here, we investigated AMP-activated protein kinase (AMPK) activation, which is a key enzyme induced by energy depletion and metabolic stress, in neuronal cells and mouse models expressing mutant superoxide dismutase 1 (SOD1) or TAR DNA binding protein 43 (TDP-43) linked to ALS. AMPK phosphorylation was sharply increased in spinal cords of transgenic SOD1G93A mice at disease onset and accumulated in cytoplasmic granules in motor neurons, but not in presymptomatic mice. AMPK phosphorylation also occurred in peripheral tissues, liver and kidney, in SOD1G93A mice at disease onset, demonstrating that AMPK activation occurs late and is not restricted to motor neurons. Conversely, AMPK activity was drastically diminished in spinal cords and brains of presymptomatic and symptomatic transgenic TDP-43A315T mice and motor neuronal cells expressing different TDP-43 mutants. We show that mutant TDP-43 induction of the AMPK phosphatase, protein phosphatase 2A (PP2A), is associated with AMPK inactivation in these ALS models. Furthermore, PP2A inhibition by okadaic acid reversed AMPK inactivation by mutant TDP-43 in neuronal cells. Our results suggest that mutant SOD1 and TDP-43 exert contrasting effects on AMPK activation which may reflect key differences in energy metabolism and neurodegeneration in spinal cords of SOD1G93A and TDP-43A315T mice. While AMPK activation in motor neurons correlates with progression in mutant SOD1-mediated disease, AMPK inactivation mediated by PP2A is associated with mutant TDP-43-linked ALS.

Entities:  

Year:  2014        PMID: 24740287      PMCID: PMC3989332          DOI: 10.1371/journal.pone.0095549

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Notice of Republication

This article was republished on March 27, 2014, to correct spacing errors that were introduced during the production process. The publisher apologizes for the errors. Please download this article again to view the correct version. The originally published, uncorrected article and the republished, corrected article are provided here for reference. Originally published, uncorrected article. Click here for additional data file. Republished, corrected article. Click here for additional data file.
  1 in total

1.  Mutant TDP-43 deregulates AMPK activation by PP2A in ALS models.

Authors:  Nirma D Perera; Rebecca K Sheean; John W Scott; Bruce E Kemp; Malcolm K Horne; Bradley J Turner
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

  1 in total
  7 in total

1.  Early ALS-type gait abnormalities in AMP-dependent protein kinase-deficient mice suggest a role for this metabolic sensor in early stages of the disease.

Authors:  Maxime Vergouts; Claudia Marinangeli; Caroline Ingelbrecht; Geraldine Genard; Olivier Schakman; Anthony Sternotte; André-Guilhem Calas; Emmanuel Hermans
Journal:  Metab Brain Dis       Date:  2015-07-09       Impact factor: 3.584

Review 2.  Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD.

Authors:  Alistair Wood; Yuval Gurfinkel; Nicole Polain; Wesley Lamont; Sarah Lyn Rea
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

Review 3.  Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments.

Authors:  Tesfaye W Tefera; Karin Borges
Journal:  Front Neurosci       Date:  2017-01-10       Impact factor: 4.677

Review 4.  Cysteine Modifications in the Pathogenesis of ALS.

Authors:  Cristiana Valle; Maria Teresa Carrì
Journal:  Front Mol Neurosci       Date:  2017-01-23       Impact factor: 5.639

5.  Targeting PP2A activates AMPK signaling to inhibit colorectal cancer cells.

Authors:  Cuiping Dai; Xuning Zhang; Da Xie; Peipei Tang; Chunmei Li; Yi Zuo; Baofei Jiang; Caiping Xue
Journal:  Oncotarget       Date:  2017-09-28

Review 6.  Mitochondrial quality control in amyotrophic lateral sclerosis: towards a common pathway?

Authors:  Bilal Khalil; Jean-Charles Liévens
Journal:  Neural Regen Res       Date:  2017-07       Impact factor: 5.135

7.  Exploring microRNA Biomarker for Amyotrophic Lateral Sclerosis.

Authors:  Y-H Taguchi; Hsiuying Wang
Journal:  Int J Mol Sci       Date:  2018-04-28       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.